Revenue and EPS are expected to grow through FY27–FY28, although earnings remain sensitive to gold prices and mining costs. Based on FY26 normalised EPS of A$0.76 and a 10–12x P/E, fair value is estimated at A$7.6–9.1 per share.
.webp&w=828&q=75)
Golden Deeps is advancing deeper drilling at Graceland after encouraging copper, silver and zinc results. Fresh assays and new targets have strengthened interest in the Namibian exploration program, while upcoming drilling will test the discovery’s potential scale.
Learn what market capitalisation means, how ASX market cap is calculated, and the key differences between small-, mid-, and large-cap stocks when comparing Australian-listed companies.
IGO (ASX: IGO) delivers strong FY26 results with disciplined execution, expanding margins at Greenbushes and Nova, and strategic portfolio optimisation aligned with global energy transition.
AVITA Medical is strengthening its commercial position as revenue growth improves, cash burn reduces, and its regenerative medicine portfolio expands. The company’s progress in product adoption and operational efficiency keeps it positioned as a speculative healthcare growth story.
.webp&w=828&q=75)